MENU
Forex Education Symbols

(TSX = xxx.TO, TSX-V = xxx.V)

AURINIA PHARMACEUTICALS INC (AUP.TO)
7.77 -0.30 (-3.72%) 10/20/2017 3:59pm
Open: 8.30 Prev Close: 8.07
High: 8.45 Low: 7.69
Volume: 142491 Market Cap: 648.68M
Year High: 14.17 Year Low: 2.75
Stock Technical Analysis
Overall       
Targets Six months: 10.07    One year: 11.10
Supports Support1: 7.20   Support2: 5.99
Resistances Resistance1: 8.62    Resistance2: 9.50 
Pivot Point 8.18 
Moving Averages MA(5): 8.17      MA(20): 8.05 

MA(100): 8.03      MA(250): 6.99 
MACD MACD(12,26): 0.08      Signal(12,26,9): 0.11 
Stochastic Oscillator %K(14,3): 16.94      %D(3): 28.60 
RSI RSI(14): 44.75 
52-Week High: 14.17  Low: 2.75  Change(%): 58.2
Average Volume(K) 3-Month: 3168  10-Days: 88
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
AUP.TO has closed above bottom band by 10.8%. Bollinger Bands are 14.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Aurinia Pharmaceuticals: An Under $10 Biotech Stock To Keep An Eye On
Mon, 16 Oct 2017 17:15:00 GMT

Aurinia Pharmaceuticals (AUPH) Looks Good: Stock Adds 7.8% in Session October ...
Mon, 16 Oct 2017 13:41:15 GMT

Why Aurinia Pharmaceuticals Could Be a Gold Mine for Growth Investors
Wed, 27 Sep 2017 12:33:45 GMT

Aurinia expands pipeline programs for voclosporin; shares ahead 2% premarket
Fri, 20 Oct 2017 12:22:30 GMT

Aurinia Pharmaceuticals Inc (AUPH) Announces Clinical Development for New ...
Fri, 20 Oct 2017 12:56:15 GMT

What Really Matters? – Juniper Networks, Inc. (JNPR), Aurinia Pharmaceuticals ...
Wed, 18 Oct 2017 16:18:45 GMT

Stoxline Canada

Stock Chart Toronto

Option Calculator

Financials
EPS -1.300
EPS Est. Current Year -0.900
EPS Est. Next Year
EPS Est. Next Quarter -0.130
Forward EPS -0.580
Shares Out. (M) 83.54
Shares Float (M) 45.01
Book Value (p.s.) 2.140
PEG Ratio
Profit Margin
Operating Margin -8070.55
Return on Assets (ttm) -17.9
Return on Equity (ttm) -70.8
Qtrly Rev. Growth 498.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.389
Qtrly Earnings Growth
Operating Cash Flow (M) -30.01
Levered Free Cash Flow (M) -17.25
Valuation
P/E -5.98
P/E Growth Ratio -0.04
P/BV 3.63
P/S 64910581760.00
P/CF -21.63